DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cinacalcet
Cinacalcet
Clinical and Biochemical Outcomes of Cinacalcet Treatment of Familial
Mimpara, INN-Cinacalcet
Paricalcitol Versus Cinacalcet Plus Low-Dose Vitamin D for the Treatment
Etelcalcetide
Estonian Statistics on Medicines 2016 1/41
Cinacalcet Administration by Gastrostomy Tube in a Child Receiving Peritoneal Dialysis Kristen R
PTH1R-Casr Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol Or Calcimimetics
Comparison Between Paricalcitol Versus Cinacalcet Therapy in the Management of Secondary Hyperparathyroidism Among Prevalent Hemodialysis Patients
Experience with Cinacalcet in Familial Hypocalciuric Hypercalcemia Resulting from Inactivating Mutations in Calcium Sensing Receptor (Casr)
Estonian Statistics on Medicines 2013 1/44
Parsabiv Pi.Pdf
Cinacalcet Corrects Biased Allosteric Modulation of Casr by AHH Autoantibody
Hyperparathyroidism – Cinacalcet HCI, Overview
Parsabiv® (Etelcalcetide)
Download Leaflet View the Patient Leaflet in PDF Format
Recurrent Pancreatitis in a Patient with Familial Hypocalciuric Hypercalcaemia Treated Successfully with Cinacalcet
Use of Paricalcitol & Cinacalcet in Patients with Kidney Failure
Top View
Calcium-Sensing Receptor in Adipose Tissue: Possible Association with Obesity-Related Elevated Autophagy
Cinacalcet Plus Vitamin D Versus Vitamin D Alone for the Treatment Of
KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
Osteoporosis in Patients with Chronic Kidney Diseases: a Systemic Review
Comparison of Efficacy and Safety of Cinacalcet Versus Calcitriol in Patients of Secondary Hyperparathyroidism in Indian Population
Product Monograph
SENSIPAR® (Cinacalcet) Tablets, for Oral Use Hypocalcemia: Life Threatening Events and Fatal Outcomes Were Initial US Approval: 2004 Reported
SENSIPAR (Cinacalcet) RATIONALE for INCLUSION in PA PROGRAM
Pharmacoeconomic Evaluation of Antibiotic Therapy of Community
Mclaren Health Plan Medicaid Prior Authorization Guidelines
Parsabiv™ (Etelcalcetide)
Teriparatide Treatment in a Heart Transplant Patient with a Chronic Kidney Disease and a Low-Turnover Bone Disease: Acasereport
Article Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Calcimimetic (Cinacalcet, Etelcalcetide) Criteria for Use January 2018
Effect of Etelcalcetide Vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis with Secondary Hyperparathyroidism a Randomized Clinical Trial
2305.Full.Pdf
Cinacalcet for Secondary Hyperparathyroidism: from Improved Mineral Levels to Improved Mortality?
Cinacalcet Rectifies Hypercalcemia in a Patient with Familial Hypocalciuric Hypercalcemia Type 2
The Use of Cinacalcet Hinders the Diagnosis Of
List Item Cinacalcet Accordpharma
An Economic Comparison of Surgical and Medical Therapy in Patients with Secondary Hyperparathyroidism—The German Perspective
Guidelines for ATC Classification and DDD Assignment 2021
CVS Caremark® Value Formulary Effective As of 07/01/2021
RAYALDEE® (Calcifediol) Extended-Release Oral Capsule
Treatment of Secondary Hyperparathyroidism in CKD Patients with Cinacalcet And/Or Vitamin D Derivatives
Cinacalcet Corrects Hypercalcemia in Mice with an Inactivating Gα11 Mutation
Effect of Switching from Cinacalcet To
Guidelines for ATC Classification and DDD Assignment 2013
List Item Mimpara : EPAR
Management of Osteoporosis in CKD
Sensipar (Cinacalcet)
Relationship Between Parathyroid Calcium-Sensing Receptor
Sensipar (Cinacalcet Hydrochloride)
Update on Clinical Trials with Cinacalcet in Secondary
Gain and Loss of Function Mutations of the Calcium-Sensing Receptor and Associated Proteins: Current Treatment Concepts
Sensipar (Cinacalcet) Drug Label, Regarding Upper Gastrointestinal (GI) Bleeding
Management of Calcium Metabolic Disorders and Osteoporosis
M10-967 Clinical Study Report R&D/10/1118
Cinacalcet Sustainedly Prevents Pancreatitis in a Child with a Compound Heterozygous SPINK1/AP2S1 Mutation
208325Orig1s000